214 related articles for article (PubMed ID: 29128118)
1. Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy.
Williams AM; Shah R; Shayne M; Huston AJ; Krebs M; Murray N; Thompson BD; Doyle K; Korotkin J; van Wijngaarden E; Hyland S; Moynihan JA; Cory-Slechta DA; Janelsins MC
J Neuroimmunol; 2018 Jan; 314():17-23. PubMed ID: 29128118
[TBL] [Abstract][Full Text] [Related]
2. Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer.
Janelsins MC; Lei L; Netherby-Winslow C; Kleckner AS; Kerns S; Gilmore N; Belcher E; Thompson BD; Werner ZA; Hopkins JO; Long J; Cole S; Culakova E
J Neuroimmunol; 2022 Jan; 362():577769. PubMed ID: 34871864
[TBL] [Abstract][Full Text] [Related]
3. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
[TBL] [Abstract][Full Text] [Related]
4. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study.
Duivon M; Lequesne J; Di Meglio A; Pradon C; Vaz-Luis I; Martin AL; Everhard S; Broutin S; Rigal O; Bousrih C; Lévy C; Lerebours F; Lange M; Joly F
Breast Cancer Res; 2024 Jun; 26(1):93. PubMed ID: 38840166
[TBL] [Abstract][Full Text] [Related]
5. Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.
Chae JW; Ng T; Yeo HL; Shwe M; Gan YX; Ho HK; Chan A
PLoS One; 2016; 11(10):e0164204. PubMed ID: 27701469
[TBL] [Abstract][Full Text] [Related]
6. Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
Chae JW; Chua PS; Ng T; Yeo AHL; Shwe M; Gan YX; Dorajoo S; Foo KM; Loh KW; Koo SL; Chay WY; Tan TJY; Beh SY; Lim EH; Lee GE; Dent R; Yap YS; Ng R; Ho HK; Chan A
Breast Cancer Res Treat; 2018 Apr; 168(3):713-721. PubMed ID: 29313215
[TBL] [Abstract][Full Text] [Related]
7. Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After Chemotherapy.
Belcher EK; Culakova E; Gilmore NJ; Hardy SJ; Kleckner AS; Kleckner IR; Lei L; Heckler C; Sohn MB; Thompson BD; Lotta LT; Werner ZA; Geer J; Hopkins JO; Corso SW; Rich DQ; van Wijngaarden E; Janelsins MC
J Natl Cancer Inst; 2022 May; 114(5):712-721. PubMed ID: 35134984
[TBL] [Abstract][Full Text] [Related]
8. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
[TBL] [Abstract][Full Text] [Related]
9. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A
Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
Fischer B
Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor superfamily molecules are increased in behavioral variant frontotemporal dementia and correlate with cortical atrophy: An exploratory investigation.
Vieira ÉLM; Caramelli P; Rocha NP; Freitas Cardoso MDG; de Miranda AS; Teixeira AL; de Souza LC
J Neuroimmunol; 2021 May; 354():577531. PubMed ID: 33711696
[TBL] [Abstract][Full Text] [Related]
12. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
13. Associations of inflammation with frailty in patients with breast cancer aged 50 and over receiving chemotherapy.
Gilmore N; Kadambi S; Lei L; Loh KP; Mohamed M; Magnuson A; Cole S; Esparaz BT; Giguere JK; Mohile S; Janelsins M
J Geriatr Oncol; 2020 Apr; 11(3):423-430. PubMed ID: 30992181
[TBL] [Abstract][Full Text] [Related]
14. Subcortical brain iron deposition and cognitive performance in older women with breast cancer receiving adjuvant chemotherapy: A pilot MRI study.
Chen BT; Ghassaban K; Jin T; Patel SK; Ye N; Sun CL; Kim H; Rockne RC; Mark Haacke E; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Somlo G; Li D; Yang R; Tan H; Katheria V; Morrison R; Hurria A
Magn Reson Imaging; 2018 Dec; 54():218-224. PubMed ID: 30076946
[TBL] [Abstract][Full Text] [Related]
15. Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
Ganz PA; Bower JE; Kwan L; Castellon SA; Silverman DH; Geist C; Breen EC; Irwin MR; Cole SW
Brain Behav Immun; 2013 Mar; 30 Suppl(Suppl):S99-108. PubMed ID: 22884417
[TBL] [Abstract][Full Text] [Related]
16. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
[TBL] [Abstract][Full Text] [Related]
18. Protocol for the "Chemobrain in Motion - study" (CIM - study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line chemotherapy.
Oberste M; Schaffrath N; Schmidt K; Bloch W; Jäger E; Steindorf K; Hartig P; Joisten N; Zimmer P
BMC Cancer; 2018 Nov; 18(1):1071. PubMed ID: 30400840
[TBL] [Abstract][Full Text] [Related]
19. Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy.
Khan MA; Garg K; Bhurani D; Agarwal NB
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1253-1265. PubMed ID: 27568029
[TBL] [Abstract][Full Text] [Related]
20. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
